EP
AMED

Elkfork Partners’s Amedisys AMED Stock Holding History

Elkfork Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$668K Hold
5,096
– – 0.02% 498
2019
Q2 		$619K Hold
5,096
– – 0.02% 519
2019
Q1 		$628K Hold
5,096
– – 0.02% 504
2018
Q4 		$597K Hold
5,096
– – 0.02% 469
2018
Q3 		$637K Buy
5,096
+1,316
+35% +$145K 0.02% 520
2018
Q2 		$323K Hold
3,780
– – 0.01% 658
2018
Q1 		$228K Hold
3,780
– – 0.01% 753
2017
Q4 		$199K Buy
3,780
+308
+9% +$16.2K 0.01% 790
2017
Q3 		$194K Buy
3,472
+448
+15% +$23.7K 0.01% 743
2017
Q2 		$190K Buy
3,024
+1,372
+83% +$79.9K 0.01% 707
2017
Q1 		$84K Sell
1,652
-196
-11% -$9.35K ﹤0.01% 797
2016
Q4 		$79K Buy
+1,848
New +$78.6K ﹤0.01% 792

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Elkfork Partners's AMED Position: Q3 2019 in Review

Elkfork Partners held its Amedisys (AMED) position steady in Q3 2019 at 5,096 shares worth $668K. The position accounts for 0.02% of the portfolio, ranked #498.

Elkfork Partners first reported a position in AMED in Q4 2016 and has held it in 12 quarters since. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Elkfork Partners held 5,096 shares of Amedisys worth $668K as of Q3 2019.
  • Elkfork Partners left its Amedisys share count unchanged in Q3 2019.
  • Amedisys made up 0.02% of Elkfork Partners's portfolio in Q3 2019, its #498 holding.
  • Elkfork Partners first reported a position in Amedisys in Q4 2016 and has held it in 12 quarters since.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.